Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Acto lanza TalkTRx™ para mejorar las conversaciones de los representantes farmacéuticos con los HCP
  • USA - English
  • USA - Français
  • USA - Deutsch
  • USA - English


News provided by

ACTO Technologies, Inc.

May 07, 2024, 08:30 ET

Share this article

Share toX

Share this article

Share toX

ACTO TalkTRx, integrated with Veeva Vault PromoMats, provides access to current and approved content stored in Vault while layering on key talking points and best practice tips for reps using the asset in HCP interactions. With the new TalkTRx product and Veeva Vault integration, ACTO will be able to sync content and information with Vault CRM, Vault PromoMats, and Vault MedComms, increasing the value for mutual customers.
ACTO TalkTRx, integrated with Veeva Vault PromoMats, provides access to current and approved content stored in Vault while layering on key talking points and best practice tips for reps using the asset in HCP interactions. With the new TalkTRx product and Veeva Vault integration, ACTO will be able to sync content and information with Vault CRM, Vault PromoMats, and Vault MedComms, increasing the value for mutual customers.
ACTO: Driving Continuous Field Force Effectiveness -- ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for Life Sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into “Masters of the Message” who engage HCPs and their support teams with authority and impact.
ACTO: Driving Continuous Field Force Effectiveness -- ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for Life Sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into “Masters of the Message” who engage HCPs and their support teams with authority and impact.

Presentado hoy en la Cumbre Comercial 2024 de Veeva, una de las mayores reuniones de Profesionales Médicos y Comerciales en Ciencias de la Vida

BOSTON, 7 de mayo de 2024 /PRNewswire/ --  ACTO ha anunciado hoy la disponibilidad de TalkTRx™, el primer producto creado para proporcionar a los representantes acceso a activos de marketing con contexto superpuesto para que puedan presentar de forma precisa y más personal a los proveedores de atención sanitaria (HCP). TalkTRx de ACTO se ha desarrollado como parte de la plataforma Intelligent Field Excellence (IFE) de la compañía, impulsada por IA y diseñada específicamente para las ciencias de la vida con el fin de ayudar a los profesionales de campo a mejorar la interacción cara a cara con los profesionales sanitarios. 

ACTO TalkTRx, integrado con Veeva Vault PromoMats, proporciona acceso al contenido actual y aprobado almacenado en Vault, a la vez que incorpora temas de conversación clave y consejos sobre las mejores prácticas para los representantes que utilizan el activo en las interacciones con los profesionales sanitarios. La integración ya está disponible y ha sido creada y suministrada por ACTO.

"Nuestros representantes utilizan la plataforma ACTO de forma regular sobre el terreno para refrescar la marca y los mensajes clínicos como preparación para las reuniones con los profesionales sanitarios", explicó Tyrone Hollie, director de Tecnología de Aprendizaje e Incorporación sobre el Terreno, Currículo de Formación y Desarrollo de Ipsen. "Aunque los representantes reciben formación sobre nuevos contenidos de marketing, les resulta difícil recordar los temas de conversación en el momento en que los necesitan. Con TalkTRx, los representantes pueden extraer el activo aprobado de Vault PromoMats en ACTO y revisar los puntos clave del mensaje en cuestión de minutos. Esto no sólo garantiza la precisión del mensaje, sino que también fomenta el uso de los recursos, lo que se traduce en un mayor compromiso del personal sanitario".

Como Veeva Silver Certified Product Partner, ACTO ya dispone de una integración certificada con Veeva CRM. Con el nuevo producto TalkTRx y la integración con Veeva Vault, ACTO podrá sincronizar el contenido y la información con Vault CRM, Vault PromoMats y Vault MedComms, aumentando el valor para los clientes mutuos.

"Los representantes sobre el terreno siguen siendo el canal más eficaz y costoso en el enfoque omnicanal de la interacción con los profesionales sanitarios", afirmó Parth Khanna, consejero delegado de ACTO. "Pero controlar el mensaje y medir el impacto de las interacciones en directo entre los representantes y los médicos es casi imposible. Sin embargo, con ACTO, estamos convirtiendo a los representantes de campo en 'Maestros del Mensaje', asegurando que sean competentes, seguros y creíbles en cada interacción HCP. Nuestra integración con Veeva Vault y TalkTRx proporciona a los representantes el contenido y el contexto que necesitan, convirtiéndolos en asesores de confianza en un entorno que es más complejo, menos indulgente y con mayores riesgos de éxito en lo que respecta al compromiso del paciente y al rendimiento de la marca".

Visite el expositor de ACTO y asista a nuestra presentación en el Innovation Theater el miércoles 8 de mayo de 8:00 a 8:15 a.m. ET en la Veeva Commercial Summit de Boston para obtener más información y ver una demostración.

Si desea más información visite la página web www.acto.com/TalkTRx.

Acerca de ACTO

ACTO es una plataforma de Excelencia de Campo Inteligente (IFE) impulsada por IA y creada para las Ciencias de la Vida que ayuda a los equipos de Ventas, Marketing y Medicina a mejorar el compromiso con el cliente y el rendimiento de la marca convirtiendo a los profesionales de campo en "Maestros del Mensaje" que interactúan con los HCP y sus equipos de apoyo con autoridad e impacto. Con ACTO, las empresas biofarmacéuticas pueden garantizar que los profesionales de campo sean siempre competentes, seguros y creíbles, transmitiendo el mensaje correcto a los profesionales sanitarios, al tiempo que proporcionan a los altos directivos y a los gestores de primera línea la información que necesitan para impulsar la eficacia continua del personal de campo.

© 2024 ACTO Technologies, Inc. | Única plataforma Intelligent Field Excellence (IFE) diseñada específicamente para las ciencias de la vida. Todos los derechos reservados. Todos los nombres de productos y servicios pertenecen a sus respectivos propietarios.

Para consultas de medios contacte con: Robert Minicucci, ACTO, [email protected], +1 339 206 1722

Foto - https://mma.prnewswire.com/media/2404923/ACTO_Technologies__Inc__ACTO_LAUNCHES_TALKTRX__TO_IMPROVE_PHARMA.jpg
Logo - https://mma.prnewswire.com/media/2404922/ACTO_Technologies__Inc__ACTO_LAUNCHES_TALKTRX__TO_IMPROVE_PHARMA.jpg 

21%

more press release views with 
Request a Demo

Modal title

Also from this source

CXZONE VON ACTO ERHÄLT ZWEI AUSZEICHNUNGEN BEI DEN 2025 PHARMACEUTICAL TECHNOLOGY EXCELLENCE AWARDS

CXZONE VON ACTO ERHÄLT ZWEI AUSZEICHNUNGEN BEI DEN 2025 PHARMACEUTICAL TECHNOLOGY EXCELLENCE AWARDS

ACTO, ein führender Anbieter von AI-first-Lösungen für Life Sciences, Veeva-Produktpartner und Mitglied des Veeva AI-Partnerprogramms, gab heute...

DOUBLE DISTINCTION POUR CXZONE D'ACTO AUX PRIX D'EXCELLENCE 2025 PHARMACEUTICAL TECHNOLOGY

DOUBLE DISTINCTION POUR CXZONE D'ACTO AUX PRIX D'EXCELLENCE 2025 PHARMACEUTICAL TECHNOLOGY

ACTO, chef de file des solutions d'excellence sur le terrain, centrées sur l'IA et destinées aux sciences de la vie, partenaire de Veeva pour les...

More Releases From This Source

Explore

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

Computer & Electronics

Computer & Electronics

Artificial Intelligence

Artificial Intelligence

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.